Antimanic effects of clonazepam.

[1]  G. Chouinard,et al.  Clonazepam in the treatment of neuroleptic-induced somnambulism. , 2006, The American journal of psychiatry.

[2]  G. Chouinard,et al.  Clonazepam in the treatment of patients with recurrent panic attacks. , 1986, The Journal of clinical psychiatry.

[3]  B. Lerer,et al.  Three cases of carbamazepine toxicity. , 1985, The American journal of psychiatry.

[4]  D. Greenspan,et al.  Use of clonazepam in a patient with schizoaffective disorder. , 1985, The American journal of psychiatry.

[5]  B. Frykholm.  Clonazepam – antipsychotic effect in a case of schizophrenia‐like psychosis with epilepsy and in three cases of atypical psychosis , 1985, Acta psychiatrica Scandinavica.

[6]  S. Young,et al.  A controlled clinical trial of l-tryptophan in acute mania , 1985, Biological Psychiatry.

[7]  B. Jones,et al.  Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. , 1985, The American journal of psychiatry.

[8]  S. Shukla,et al.  Lithium-carbamazepine neurotoxicity and risk factors. , 1984, The American journal of psychiatry.

[9]  B. Yerevanian,et al.  Case report of a possible interaction between neuroleptics and carbamazepine. , 1984, The American journal of psychiatry.

[10]  I. Bell,et al.  Use of clonazepam in mania and schizoaffective disorders. , 1984, The American journal of psychiatry.

[11]  L. M. Brenner,et al.  Tardive dyskinesia. A discontinuation study. , 1984, Archives of general psychiatry.

[12]  S. Young,et al.  Antimanic effect of clonazepam. , 1983, Biological psychiatry.

[13]  D. Weinberger,et al.  Clonazepam treatment of chronic schizophrenia: negative results in a double-blind, placebo-controlled trial. , 1982, The American journal of psychiatry.

[14]  J. Kane,et al.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979 , 1982, Archives of general psychiatry.

[15]  J. Kane,et al.  Research diagnoses for tardive dyskinesia. , 1982, Archives of general psychiatry.

[16]  G. Chouinard,et al.  ETHOPROPAZINE VS BENZTROPINE IN NEUROLEPTIC-INDUCED PARKINSONISM , 1979, The Journal of clinical psychiatry.

[17]  P. J. Walsh,et al.  Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam. , 1978, British medical journal.

[18]  C. Marsden,et al.  Altered 5‐HT metabolism with clonazepam, diazepam and diphenylhydantoin , 1975, The Journal of pharmacy and pharmacology.

[19]  G. Chouinard,et al.  A five year follow-up study of tardive dyskinesia. , 1986, Psychopharmacology bulletin.

[20]  Freinhar Jp,et al.  Use of clonazepam in two cases of acute mania. , 1985 .

[21]  W. Haefely,et al.  Benzodiazepine binding sites: receptors or acceptors? , 1982 .

[22]  M. Hallett,et al.  Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. , 1977, Brain : a journal of neurology.